Yumanity Therapeutics (FRA:8IY) ROE % Adjusted to Book Value : -64.36% (As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics ROE % Adjusted to Book Value?

Yumanity Therapeutics's ROE % for the quarter that ended in Sep. 2022 was -208.52%. Yumanity Therapeutics's PB Ratio for the quarter that ended in Sep. 2022 was 3.24. Yumanity Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2022 was -64.36%.

Yumanity Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Yumanity Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics ROE % Adjusted to Book Value Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

ROE % Adjusted to Book Value

-77.88

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-34.39	-113.67	-195.79	-88.71	-64.36

Competitive Comparison of Yumanity Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Yumanity Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yumanity Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's ROE % Adjusted to Book Value falls into.

Yumanity Therapeutics ROE % Adjusted to Book Value Calculation

Yumanity Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-104.36%	/	1.34
	=	-77.88%

Yumanity Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-208.52%	/	3.24
	=	-64.36%

Yumanity Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines